Participated · Equity · Sep 2023

Virgin Voyages operates as an exclusively adult cruise brand delivering vacations at sea, currently departing from Miami, Barcelona and Athens and soon adding Melbourne. The fleet offers more than 60 itineraries and sails to 100 ports of call. On board, passengers can choose from 20+ eateries featuring culinary experiences from Michelin-star chefs, use stylish workout spaces and attend daily group fitness classes, and enjoy a festival-like lineup of shows. The company is led by CEO Nirmal Saverimuttu and emphasizes an innovative, customer-focused experience. Virgin Voyages intends to consolidate its financial position while supporting rapid expansion into international markets. The brand positions its product around upscale dining, wellness, and entertainment offerings to differentiate in the cruise sector.

Participated · Series A · Jun 2023

Oova offers the Oova Kit, an at‑home FDA‑registered urine test that measures luteinizing hormone and progesterone and provides personalized analytics and real‑time action plans. The product is HIPAA‑compliant and can sync and share results with clinicians through its platform. The company has launched a $99/month Oova Membership that includes the kit, personalized support via an Oova Provider network, and access to a community. Oova says it has trained models on over 10,000 monitored cycles and collects daily hormone measurements across tens of thousands of cycles, and has seen adoption grow across consumer and clinical channels. The platform now works with over 100 clinics (up from 75 at launch) and is being used for use cases beyond ovulation, including early pregnancy and postpartum. Founder and CEO Amy Divaraniya, Ph.D., has indicated the company is eyeing additional phases of women’s health beyond fertility. Oova offers an at-home testing kit and mobile app that quantitatively measures luteinizing hormone and progesterone using disposable urine cartridges, letting users and clinicians track hormone profiles and confirm ovulation. The kit ships with a handle holder, 15 disposable cartridges and an app that scans test results and provides actionable guidance; physicians can also view patient data. The company says its test is unique in measuring both LH and progesterone and tracking hormones over time as an alternative to daily clinical blood draws. Oova was founded in 2017 by Amy Divaraniya, who developed the product based on personal fertility challenges, and the startup is New York–based. The product is priced at $159.99 for a starter kit and $99.99 per month for refills, and the platform is used by over 75 fertility clinics. Oova plans to add estrogen to its panel, expand beyond fertility into other hormonal and chronic health areas, add more features and pursue a rebrand using the new funding. OOVA’s first product is a mail-order fertility monitoring kit containing 20 disposable urine tests that users scan with a smartphone to receive results. The test initially measures luteinizing hormone and progesterone and the companion app tracks those hormones over time to deliver personalized trend reports based on an individual baseline. The company has working prototypes of the device and app, has completed a beta test, and is currently taking pre-orders. The $1 million seed will fund the company’s final push into the market, covering final R&D and manufacturing steps. OOVA already secured a commercial partner, Thorne Research, which will pilot sales by pairing supplements with OOVA diagnostic kits and can leverage a network of over 35,000 clinicians. Looking ahead, the company plans to expand pilots into other areas of women’s healthcare, including postpartum support and ectopic pregnancy-related services. Competitors in the smartphone-connected urinalysis space mentioned include Mira, Inui Health, Healthy.io, Scanwell and TestCard.

Participated · Series A · May 2023

Waterplan provides a SaaS platform powered by artificial intelligence models that combines satellite imagery, real-time climate change data from public and proprietary sources, and private company information to measure, respond and report on changing water risk. The platform is used by corporate customers including ABInBev, AWS, Danone, Diageo, Kurita, The Nature Conservancy and Sigma. The company plans to use new capital to accelerate research and product development, advance the science in water risk management, and innovate on its product platform to improve customer experience. Waterplan also intends to expand its presence across the United States, Europe, Latin America and Asia. The company is led by CEO Jose Ignacio Galindo and recently added Adeyemi Ajao of Base10 Partners to its board. Its most recent financing brings its total capital raised to date to $18.5M. Waterplan is a B2B SaaS platform that harnesses artificial intelligence to analyze climate data models and water data to identify water supply vulnerabilities and quantify associated financial risks. The platform enables companies in water‑reliant industries—agriculture, food and beverages, paper products, and apparel manufacturing—to monitor water security, conserve water, protect waterways from pollution, and proactively prevent supply disruptions. Founded in 2020 and a participant in Y Combinator’s Summer 2021 cohort, the company’s leadership includes CEO José Ignacio Galindo, CSO Nicolas Wertheimer, COO Olivia Cesio, CPO Matias Comercio, and Chief Scientist Jay Famiglietti. Waterplan has helped measure, mitigate, and adapt to water risk for 10 Fortune 500 companies, including Coca‑Cola, Colgate, and McCain Foods. In April 2022 it closed a $7.0M seed funding round. The new capital will be used to grow the team and to refine and improve the product and customer experience as the company pursues a water‑secure world. Waterplan is a SaaS platform that analyzes and tracks corporate water risk and potential mitigation strategies for climate-conscious companies. The founders—Jose Galindo, Nicolas Wertheimer, Matias Comercio and Olivia Cesio—built the company after years in the environmental sector and went through Y Combinator’s Summer 2021 cohort. Waterplan distills satellite imagery (canopy, water bodies, multi-year trends) and combines it with measurements from water and environmental authorities to produce location-specific risk analyses. Its product automates work typically done episodically by environmental consultants, turning large data inputs into predictive risk and mitigation outputs tailored to a company’s local context. The company plans to ramp development by hiring engineers and hydrologists to expand the platform and make its insights more widely available after gaining traction with private customers. Financially, Waterplan closed a $2.6 million seed round to fund development and go-to-market efforts.

Participated · Equity · Apr 2023

Lightyear is a European investment platform that has expanded rapidly across the continent, now active in 25 markets and available in 10 languages. The product suite includes business accounts (launched in 18 countries), more than 6,000 tradable instruments, fractional European shares, and local tax wrapper products. The company recently introduced three AI-powered market intelligence tools—Why Did It Move, Bulls Say/Bears Say, and Lightning Updates—and plans to broaden its AI capabilities toward comprehensive wealth management tools for retail investors. Lightyear reported reaching $1 billion in customer assets, a milestone tied to recent growth across the UK and Europe. The team emphasizes removing barriers to investing in Europe’s fragmented regulatory and tax landscape and aims to increase retail participation across the region. Expansion into new markets, including Denmark, Sweden, and Bulgaria, is a stated near-term priority. Lightyear is a mobile-first stock-trading app that enables retail investors to buy, manage and track portfolios of major global companies. Founded in London in 2020 and launched from stealth in 2021, the company expanded into mainland Europe last summer. Its core product includes mobile trading, portfolio management and performance tracking; the newly launched web app brings big-screen access and most core features. The initial web release includes a chart-drag view for custom time frames but omits some mobile features—such as the personalized events calendar, analyst price targets and fund highlights—which the company says will be added over time. Lightyear plans additional web-only features in the long run. Financially, the company has secured about $35 million from institutional and angel backers including Lightspeed Venture Partners, Virgin Group and Taavet Hinrikus. Lightyear is a London-based fintech that offers commission-free trading on U.S. and European stocks and exchange-traded funds (ETFs). The company charges no account fees or per-trade commissions and relies on foreign-exchange fees, charging 0.35% on conversions above £3,000 ($3,500) per month. After users convert, they hold funds in a local-currency account and can trade without additional per-trade fees. Lightyear was built by early Wise employees Martin Sokk and Mihkel Aamer, and Wise co-founder Taavet Hinrikus is also an investor. The startup launched out of stealth in the U.K. last year and is now expanding into 19 new European markets. The company has raised $25 million to power that expansion and to scale operations amid a competitive field that includes incumbents like Freetrade and potential rivals such as Robinhood. Lightyear is a London- and Tallinn-based fintech founded by ex-Wise duo Martin Sokk and Mihkel Aamer. The company combines multi-currency accounts with access to global markets and has launched an MVP that provides access to more than 1,000 global stocks. Lightyear says it will onboard customers from its waiting list as it expands. The additional funding will be used to expand operations and support development and launch efforts. The company is targeting a pan-European launch in H1 2022. Earlier this summer Lightyear raised a $1.5M pre-seed from a cohort led by Taavet Hinrikus, Sten Tamkivi and Jaan Tallinn. Lightyear is building a mobile stock trading app focused on truly commission-free trading and lower FX fees. The app will offer 1,500 stocks and ETFs from multiple markets at launch and charges no account, trading, or FX fees up to £3,000 per month, after which a 0.35% FX fee applies. Lightyear has opened a waitlist and plans to roll out the product during the third quarter. The company was founded by ex‑Wise employees Martin Sokk (CEO) and Mihkel Aamer (CTO), who held senior roles at Wise. Lightyear has raised a $1.5M pre-seed round with participation from a new fund formed by Taavet Hinrikus and Sten Tamkivi, Jaan Tallinn via Metaplanet, and several business angels. The startup will compete with well-funded challengers like Trade Republic and established UK players such as Freetrade (which has 600,000 users).

Participated · Series A · Feb 2023

Marker Learning offers remote learning and attention-disability evaluations and ongoing support, leveraging proprietary technology and a network of psychologists and educators. The company delivers comprehensive diagnostic reports within one month that can be submitted to schools or employers and used to secure test accommodations. Marker partners with school districts to act as an extension of special education teams and already reaches 1 million students through those partnerships. It aims to provide services at a fraction of the cost of traditional private evaluations—which can cost up to $14,000 and have waitlists beyond 24 months—to improve equity for students of color and low-income households. With Series A funding, Marker plans to expand into new geographies and broaden its platform to include tutoring, coaching, and other learning support services for individuals and schools. Co-founders Stefan Bauer and Emily Yudofsky, both diagnosed with dyslexia, lead the company. The company announced a $15 million Series A led by Andreessen Horowitz. Marker Learning operates a telepsychology platform that enables psychologists to virtually administer evidence-based learning disability assessments and deliver personalized action plans. The company partners with leading psychologists and learning-disability specialists and leverages proprietary technology to streamline the assessment process, reduce cost, and decrease turnaround time versus in-person services. Evaluations for dyslexia and other learning disabilities often cost over $10,000 and many cases go undiagnosed; Marker aims to make gold-standard assessments more accessible to schools and families. The platform was developed to address long waitlists and access issues that were exacerbated by the COVID-19 pandemic. Marker plans to use new funding to expand its team and accelerate geographic expansion across the United States. Co-founders Stefan Bauer and Emily Yudofsky started the company after their own diagnoses and bring experience from McKinsey, Google, and telemedicine entrepreneurship.